Webinar: Accelerating Upstream Bioprocess Development With Scalable, Single-Use Cell Culture Systems

Webinar On-Demand: Accelerate Upstream Processing With Scalable, Single-Use Cell Culture Systems

Explore the benefits of moving from traditional bioreactors to single-use Ambr^® 250 Modular and Biostat STR^® systems to enhance speed, scalability, and cost-efficiency from process development to commercial manufacturing.

What You Will Learn

Understand how project timelines can be reduced by transitioning from traditional glass bioreactors to the Ambr^® 250 Modular system
Deepen process understanding by implementing high-throughput upstream process development tools to mitigate risks at the manufacturing scale
Learn how Biostat STR^® enables flexible project operation and advanced process control, with the capability to switch from fed-batch to perfusion mode for process intensification

Clear form data

Consult Our Experts

First Name *

Last Name *

E-Mail *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Complete Form to Register

Alison Rees-Manley

Product Manager, PD Bioreactor Technologies

Alison Rees-Manley is a product manager within the Bioreactor Technologies group at Sartorius. In this role, Alison has global responsibility for Ambr^® 15, Ambr^® 250 Modular and Biostat^® B instruments. Previously, Alison held the role of Field Application Specialist, providing bioreactor expertise and technical support in North Europe.

Before joining Sartorius, Alison held positions within upstream process development at Cantab Pharmaceuticals, Xenova Biomanufacturing, and Pfizer, gaining more than ten years of experience working with cell culture and fermentation.

Ahmed Youssef

Senior Manager, Upstream Process Development, Ascend Advanced Therapies

Ahmed Youssef is a senior manager of upstream process development at Ascend. He leads the team responsible for developing safe and effective gene therapies for partners using AAVs. In this role, he draws on more than 12 years of bioprocessing expertise to take AAV gene therapies from the lab to patients by ensuring they can be produced on a large scale with the best possible quality.

Ahmed has a comprehensive background in process development, scale-up, process transfer, and team leadership. He has worked across molecules (mAbs, AAVs, and hormones), including those already in late-stage clinical trials.